1. Home
  2. GLDD vs DRUG Comparison

GLDD vs DRUG Comparison

Compare GLDD & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Great Lakes Dredge & Dock Corporation

GLDD

Great Lakes Dredge & Dock Corporation

HOLD

Current Price

$16.96

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$69.90

Market Cap

707.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLDD
DRUG
Founded
1890
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Pharmaceuticals and Biotechnology
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
707.1M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
GLDD
DRUG
Price
$16.96
$69.90
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$17.00
$124.00
AVG Volume (30 Days)
1.5M
81.6K
Earning Date
05-26-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
28.57
N/A
EPS
1.08
N/A
Revenue
$702,503,000.00
N/A
Revenue This Year
$3.79
N/A
Revenue Next Year
$9.01
N/A
P/E Ratio
$15.69
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.51
$23.18
52 Week High
$16.99
$123.75

Technical Indicators

Market Signals
Indicator
GLDD
DRUG
Relative Strength Index (RSI) 67.65 36.51
Support Level $14.60 $49.47
Resistance Level $16.99 $84.29
Average True Range (ATR) 0.04 4.10
MACD -0.09 -1.10
Stochastic Oscillator 80.00 8.74

Price Performance

Historical Comparison
GLDD
DRUG

About GLDD Great Lakes Dredge & Dock Corporation

Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: